CEL-SCI's Talor to deliver Multikine keynote at global congress on otolaryngology, head and neck surgery
CVM•CEL-SCI will attend a Lisbon congress on June 9-10, 2027, where Chief Scientific Officer Eyal Talor will give a keynote on Multikine Phase 3 findings and biomarker-based patient selection before surgery.
1. Keynote at Lisbon congress
CEL-SCI said it will attend the 3rd Global Congress on Otolaryngology, Head and Neck Surgery in Lisbon, Portugal, on June 9-10, 2027. Chief Scientific Officer Eyal Talor will deliver a keynote on Multikine Phase 3 findings, focusing on biomarker-based patient selection before surgery.
